Cargando…
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth
BACKGROUND: Numerous studies have demonstrated that functional mitochondria are required for tumorigenesis, suggesting that mitochondrial oxidative phosphorylation (OXPHOS) might be a potential target for cancer therapy. In this study, we investigated the effects of BAY 87-2243, a small molecule tha...
Autores principales: | Schöckel, Laura, Glasauer, Andrea, Basit, Farhan, Bitschar, Katharina, Truong, Hoa, Erdmann, Gerrit, Algire, Carolyn, Hägebarth, Andrea, Willems, Peter HGM, Kopitz, Charlotte, Koopman, Werner JH, Héroult, Mélanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615872/ https://www.ncbi.nlm.nih.gov/pubmed/26500770 http://dx.doi.org/10.1186/s40170-015-0138-0 |
Ejemplares similares
-
Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells
por: Basit, Farhan, et al.
Publicado: (2017) -
BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I
por: Ellinghaus, Peter, et al.
Publicado: (2013) -
Identification of K(Ca)3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines
por: Kovalenko, Ilya, et al.
Publicado: (2016) -
Complex I and complex III inhibition specifically increase cytosolic hydrogen peroxide levels without inducing oxidative stress in HEK293 cells
por: Forkink, Marleen, et al.
Publicado: (2015) -
BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts
por: Helbig, Linda, et al.
Publicado: (2014)